Cargando…
Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242167/ https://www.ncbi.nlm.nih.gov/pubmed/37287965 http://dx.doi.org/10.3389/fimmu.2023.1218845 |
| _version_ | 1785054155937677312 |
|---|---|
| author | Zhang, Er-lei |
| author_facet | Zhang, Er-lei |
| author_sort | Zhang, Er-lei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10242167 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102421672023-06-07 Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy Zhang, Er-lei Front Immunol Immunology Frontiers Media S.A. 2023-05-23 /pmc/articles/PMC10242167/ /pubmed/37287965 http://dx.doi.org/10.3389/fimmu.2023.1218845 Text en Copyright © 2023 Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Zhang, Er-lei Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy |
| title | Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy |
| title_full | Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy |
| title_fullStr | Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy |
| title_full_unstemmed | Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy |
| title_short | Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy |
| title_sort | editorial: immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242167/ https://www.ncbi.nlm.nih.gov/pubmed/37287965 http://dx.doi.org/10.3389/fimmu.2023.1218845 |
| work_keys_str_mv | AT zhangerlei editorialimmunomodulatoryfactorsconversionandpostoperativeadjuvanttherapyforhepatobiliarytumorsbasedonimmunotherapy |